Hiv-1 Vpr displays natural protein-transducing properties: Implications for viral pathogenesis

Virology

Volumn 302, Issue 1, 2002, Pages 95-105

  Sherman, Michael P ^a   Schubert, Ulrich ^b,c   Williams, Samuel A ^a   De Noronha, Carlos M C ^a   Kreisberg, Jason F ^a   Henklein, Peter ^c,d   Greene, Warner C ^a,e  

^a GLADSTONE INSTITUTE OF VIROLOGY AND IMMUNOLOGY   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

^d HUMBOLDT UNIVERSITY   (Germany)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cell cycle; HIV; Protein transduction; Vpr

Indexed keywords

BETA GALACTOSIDASE; DNA BINDING PROTEIN; HYBRID PROTEIN; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR; VPR PROTEIN;

APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL PROLIFERATION; CEREBROSPINAL FLUID; CONTROLLED STUDY; DROSOPHILA; HOMEOBOX; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIFE CYCLE; MACROPHAGE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DENATURATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; VIRUS REPLICATION;

HUMAN HERPESVIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; SIMPLEXVIRUS;

EID: 0036435587     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2002.1576     Document Type: Article

References (93)

1. Adachi, A., Gendelman, H. E., Koenig, S., Folks, T., Willey, R., Rabson, A., and Martin, M. A. (1986). Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59(2), 284-291.
2. Anderson, D. C., Nichols, E., Manger, R., Woodle, D., Barry, M., and Fritzberg, A. R. (1993). Tumor cells retention of antibody Fab fragments is enhanced by an attached HIV TAT protein-derived peptide. Biochem. Biophys. Res. Commun. 194(2), 876-884.
3. Ayyavoo, V., Mahboubi, A., Mahalingam, S., Ramalingam, R., Kudchodkar, S., Williams, W. V., Green, D. R., and Weiner, D. B. (1997). HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor kappa B [see comments]. Nat. Med. 3(10), 1117-1123.
4. Azad, A. A. (2000). Could Nef and Vpr proteins contribute to disease progression by promoting depletion of bystander cells and prolonged survival of HIV-infected cells? Biochem. Biophys. Res. Commun. 267(3), 677-685.
5. Bartz, S. R., Rogel, M. E., and Emerman, M. (1996). Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G2 accumulation by a mechanism which differs from DNA damage checkpoint control. J. Virol. 70(4), 2324-2331.
6. Bonifaci, N., Sitia, R., and Rubartelli, A. (1995). Nuclear translocation of an exogenous fusion protein containing HIV Tat requires unfolding. AIDS 9(9), 995-1000.
7. Bouyac-Bertoia, M., Dvorin, J. D., Fouchier, R. A., Jenkins, Y., Meyer, B. E., Wu, L. I., Emerman, M., and Malim, M. H. (2001). HIV-1 infection requires a functional integrase NLS. Mol. Cell 7(5), 1025-1035.
8. Bukrinsky, M. I., Haggerty, S., Dempsey, M. P., Sharova, N., Adzhubel, A., Spitz, L., Lewis, P., Goldfarb, D., Emerman, M., and Stevenson, M. (1993). A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells [see comments]. Nature 365(6447), 666-669.
9. Bukrinsky, M. I., Sharova, N., Dempsey, M. P., Stanwick, T. L., Bukrinskaya, A. G., Haggerty, S., and Stevenson, M. (1992). Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. Proc. Natl. Acad. Sci. USA 89(14), 6580-6584.
10. Campbell, B. J., and Hirsch, V. M. (1997). Vpr of simian immunodeficiency virus of African green monkeys is required for replication in macaque macrophages and lymphocytes. J. Virol. 7(7), 5593-5602.
11. Chambers, C. A., and Allison, J. P. (1999). Costimulatory regulation of T cell function. Curr. Opin. Cell Biol. 11(2), 203-210.
12. Cohen, E. A., Dehni, G., Sodroski, J. G., and Haseltine, W. A. (1990). Human immunodeficiency virus Vpr product is a virion-associated regulatory protein. J. Virol. 64(6), 3097-3099.
13. Connor, R. I., Chen, B. K., Choe, S., and Landau, N. R. (1995). Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 206(2), 935-944.
14. Conti, L., Matarrese, P., Varano, B., Gauzzi, M. C., Sato, A., Malorni, W., Belardelli, F., and Gessani, S. (2000). Dual role of the HIV-1 Vpr protein in the modulation of the apoptotic response of T cells. J. Immunol. 165(6), 3293-3300.
15. Conti, L., Rainaldi, G., Matarrese, P., Varano, B., Rivabene, R., Columba, S., Sato, A., Belardelli, F., Malorni, W., and Gessani, S. (1998). The HIV-1 Vpr protein acts as a negative regulator of apoptosis in a human lymphoblastoid T cells line: Possible implications for the pathogenesis of AIDS. J. Exp. Med. 187(3), 403-413.
16. de Noronha, C. M., Sherman, M. P., Lin, H. W., Cavrois, M. V., Moir, R. D., Goldman, R. D., and Greene, W. C. (2001). Dynamic disruptions in nuclear envelope architecture and integrity induced by HIV-1 Vpr. Science 294(5544), 1105-1108.
17. Derossi, D., Calvet, S., Trembleau, A., Brunissen, A., Chassaing, G., and Prochiantz, A. (1996). Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent. J. Biol. Chem. 271(30), 18188-18193.
18. Eckstein, D. A., Sherman, M. P., Penn, M. L., Chin, P. S., De Noronha, C. M., Greene, W. C., and Goldsmith, M. A. (2001). HIV-1 Vpr enhances viral burden by facilitating infection of tissue macrophages but not nondividing CD4(+) T cells. J. Exp. Med. 194(10), 1407-1419.
19. Ehrenreich, H., Rieckmann, P., Sinowatz, F., Weih, K. A., Arthur, L. O., Goebel, F. D., Burd, P. R., Coligan, J. E., and Clouse, K. A. (1993). Potent stimulation of monocytic endothelin-1 production by HIV-1 glycoprotein 120. J. Immunol. 150(10), 4601-4609.
20. Elliott, G., and O'Hare, P. (1997). Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell 88(2), 223-233.
21. Ensoli, B., and Cafaro, A. (2000). Control of viral replication and disease onset in cynomolgus monkeys by HIV-1 Tat vaccine. J. Biol. Regul. Homeost. Agents 14(1), 22-26.
22. Ensoli, B., Gendelman, R., Markham, P., Fiorelli, V., Colombini, S., Raffeld, M., Cafaro, A., Chang, H. K., Brady, J. N., and Gallo, R. C. (1994). Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma. Nature 371(6499), 674-680.
23. Fawell, S., Seery, J., Daikh, Y., Moore, C., Chen, L. L., Pepinsky, B., and Barsoum, J. (1994). Tat-mediated delivery of heterologous proteins into cells. Proc. Natl. Acad. Sci. USA 91(2), 664-668.
24. Ferri, K. F., Jacotot, E., Blanco, J., Este, J. A., and Kroemer, G. (2000). Mitochondrial control of cell death induced by HIV-1-encoded proteins. Ann. NY Acad. Sci. 926, 149-164.
25. Finkel, T. H., Tudor-Williams, G., Banda, N. K., Cotton, M. F., Curiel, T., Monks, C., Baba, T. W., Ruprecht, R. M., and Kupfer, A. (1995). Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nat. Med. 1(2), 129-134.
26. Fouchier, R. A., Meyer, B. E., Simon, J. H., Fischer, U., and Malim, M. H. (1997). HIV-1 infection of non-dividing cells: Evidence that the amino-terminal basic region of the viral matrix protein is important for Gag processing but not for post-entry nuclear import. EMBO J. 16(15), 4531-4539.
27. Frankel, A. D., and Pabo, C. O. (1988). Cellular uptake of the tat protein from human immunodeficiency virus. Cell 55(6), 1189-1193.
28. Freed, E. O., and Martin, M. A. (1994). HIV-1 infection of non-dividing cells. Nature 369(6476), 107-108.
29. Gallay, P., Hope, T., Chin, D., and Trono, D. (1997). HIV-1 infection of nondividing cells through the recognition of integrase by the impor-tin/karyopherin pathway. Proc. Natl. Acad. Sci. USA 94(18), 9825-9830.
30. Gallay, P., Stitt, V., Mundy, C., Oettinger, M., and Trono, D. (1996). Role of the karyopherin pathway in human immunodeficiency virus type 1 nuclear import. J. Virol. 70(2), 1027-1032.
31. Gibbs, J. S., and Desrosiers, R. C. (1993). Auxillary proteins of the primate immunodeficiency viruses. In "Frontiers in Molecular Biology: Human Retroviruses" (B. R. Cullen, Ed.), pp. 137-158. Oxford Univ. Press, New York.
32. Goh, W. C., Rogel, M. E., Kinsey, C. M., Michael, S. F., Fultz, P. N., Nowak, M. A., Hahn, B. H., and Emerman, M. (1998). HIV-1 Vpr increases viral expression by manipulaton of the cell cycle: A mechanism for selection of Vpr in vivo. Nat. Med. 4(1), 65-71.
33. Green, M., and Loewenstein, P. M. (1988). Autonomous functional domains of chemically synthesized human immunodeficiency virus Tat trans-activator protein. Cell 55(6), 1179-1188.
34. Groux, H., Torpier, G., Monte, D., Mouton, Y., Capron, A., and Ameisen, J. C. (1992). Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals. J. Exp. Med. 175(2), 331-340.
35. Hawiger, J. (1999). Noninvasive intracellular delivery of functional peptides and proteins. Curr. Opin. Chem. Biol. 3(1), 89-94.
36. He, J., Choe, S., Walker, R., Di Marzio, P., Morgan, D. O., and Landau, N. R. (1995). Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J. Virol. 69(11), 6705-6711.
37. Heinzinger, N. K., Bukinsky, M. I., Haggerty, S. A., Ragland, A. M., Kewalramani, V., Lee, M. A., Gendelman, H. E., Ratner, L., Stevenson, M., and Emerman, M. (1994). The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc. Natl. Acad. Sci. USA 91(15), 7311-7315.
38. Henklein, P., Bruns, K., Sherman, M. P., Tessmer, U., Licha, K., Kopp, J., de Noronha, C. M., Greene, W. C., Wray, V., and Schubert, U. (2000). Functional and structural characterization of synthetic HIV-1 Vpr that transduces cells, localizes to the nucleus, and induces G2 cell cycle arrest. J. Biol. Chem. 275(41), 32016-32026.
39. Ho, A., Schwarze, S. R., Mermelstein, S. J., Waksman, G., and Dowdy, S. F. (2001). Synthetic protein transduction domains: Enhanced transduction potential in vitro and in vivo. Cancer Res. 61(2), 474-477.
40. Hrimech, M., Yao, X. J., Bachand, F., Rougeau, N., and Cohen, E. A. (1999). Human immunodeficiency virus type 1 (HIV-1) Vpr functions as an immediate-early protein during HIV-1 infection. J. Virol. 73(5), 4101-4109.
41. Huang, M. B., Weeks, O., Zhao, L. J., Saltarelli, M., and Bond, V. C. (2000). Effects of extracellular human immunodeficiency virus type 1 Vpr protein in primary rat cortical cell cultures. J. Neurovirol. 6(3), 202-220.
42. Jenkins, Y., McEntee, M., Weis, K., and Greene, W. C. (1998). Characterization of HIV-1 Vpr nuclear import: Analysis of signals and pathways. J. Cell. Biol. 143(4), 875-885.
43. Joliot, A., Maizel, A., Rosenberg, D., Trembleau, A., Dupas, S., Volovitch, M., and Prochiantz, A. (1998). Identification of a signal sequence necessary for the unconventional secretion of Engrailed homeoprotein. Curr. Biol. 8(15), 856-863.
44. Jowett, J. B., Planelles, V., Poon, B., Shah, N. P., Chem, M. L., and Chen, I. S. (1995). The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 3 M phase of the cell cycle. J. Virol. 69 (10), 6304-6313.
45. Karni, O., Friedler, A., Zakai, N., Gilon, C., and Loyter, A. (1998). A peptide derived from the N-terminal region of HIV-1 Vpr promotes nuclear import in permeabilized cells: Elucidation of the NLS region of the Vpr. FEBS Lett. 429(3), 421-425.
46. Levy, D. N., Refaeli, Y., MacGregor, R. R., and Weiner, D. B. (1994). Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 91(23), 10873-10877.
47. Levy, D. N., Refaeli, Y., and Weiner, D. B. (1995). Extracellular Vpr protein increases cellular permissiveness to human immunodeficiency virus replication and reactivates virus from latency. J. Virol. 69(2), 1243-1252.
48. Loret, E. P., Vives, E., Ho, P. S., Rochat, H., Van Rietschoten, J., and Johnson, W. C., Jr. (1991). Activating region of HIV-1 Tat protein: Vacuum UV circular dichroism and energy minimization. Biochemistry 30(24), 6013-6023.
49. Lu, Y. L., Spearman, P., and Ratner, L. (1993). Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions. J. Virol. 67(11), 6542-6550.
50. Luo, Z., Butcher, D. J., Murali, R., Srinivasan, A., and Huang, Z. (1998). Structural studies of synthetic peptide fragments derived from the HIV-1 Vpr protein. Biochem. Biophys. Res. Commun. 244(3), 732-736.
51. Mellman, I. (1996). Endocytosis and molecular sorting. Annu. Rev. Cell. Dev. Biol. 12, 575-625.
52. Meyaard, L., Otto, S. A., Jonker, R. R., Mijnster, M. J., Keet, R. P., and Miedema, F. (1992). Programmed death of T cells in HIV-1 infection. Science 257(5067), 217-219.
53. Miller, M. D., Farnet, C. M., and Bushman, F. D. (1997). Human immunodeficiency virus type 1 preintegration complexes: Studies of organization and composition. J. Virol. 71(7), 5382-5390.
54. Nagahara, H., Vocero-Akbani, A. M., Snyder, E. L., Ho, A., Latham, D. G., Lissy, N. A., Becker-Hapak, M., Ezhevsky, S. A., and Dowdy, S. F. (1998). Transduction of full-length Tat fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration. Nat. Med. 4(12), 1449-1452.
55. Ott, M., Emiliani, S., Van Lint, C., Herbein, G., Lovett, J., Chirmule, N., McCloskey, T., Pahwa, S., and Verdin, E. (1997). Immune hyperactivation of HIV-1-infected T cells mediated by Tat and the CD28 pathway. Science 275(5305), 1481-1485.
56. Pastan, I. H., and Willingham, M. C. (1981). Journey to the center of the cell: Role of the receptosome. Science 214(4520), 504-509.
57. Pauza, C. D., Trivedi, P., Wallace, M., Ruckwardt, T. J., Le Buanec, H., Lu, W., Bizzini, B., Burny, A., Zagury, D., and Gallo, R. C. (2000). Vaccination with Tat toxoid attenuates disease in simian/HIV-challenged macaques. Proc. Natl. Acad. USA 97(7), 3515-3519.
58. Paxton, W., Connor, R. I., and Landau, N. R. (1993). Incorporation of Vpr into human immunodeficiency virus type 1 virions: Requirement for the p6 region of gag and mutational analysis. J. Virol. 67(12), 7229-7237.
59. Perez, F., Joliot, A., Bloch-Gallego, E., Zahraoui, A., Triller, A., and Prochiantz, A. (1992). Antennapedia homeobox as a signal for the cellular internalization and nuclear addressing of a small exogenous peptide. J. Cell. Sci. 102(Pt. 4), 717-722.
60. Petit, C., Schwartz, O., and Mammano, F. (2000). The karyophilic properties of human immunodeficiency virus type 1 integrase are not required for nuclear import of proviral DNA. J. Virol. 74(15), 7119-7126.
61. Piller, S. C., Ewart, G. D., Jans, D. A., Gage, P. W., and Cox, G. B. (1999). The amino-terminal region of Vpr from human immunodeficiency virus type 1 forms ion channels and kills neurons. J. Virol. 73(5), 4230-4238.
62. Piller, S. C., Ewart, G. D., Premkumar, A., Cox, G. B., and Gage, P. W. (1996). Vpr protein of human immunodeficiency virus type 1 forms cation-selective channels in planar liquid bilayers. Proc. Natl. Acad. Sci. USA 93(1), 111-115.
63. Piller, S. C., Jans, P., Gage, P. W., and Jans, D. A. (1998). Extracellular HIV-1 virus protein R causes a large inward Current and cell death in cultured hippocampal neurons: Implications for AIDS pathology. Proc. Natl. Acad. Sci. USA 95(8), 4595-4600.
64. Poon, B., Grovit-Ferbas, K., Stewart, S. A., and Chen, I. S. Y. (1998). Cell cycle arrest by Vpr in HIV-1 virions and insensitivity to antiretroviral agents. Science 281(5374), 266-269.
65. Popov, S., Rexach, M., Zybarth, G., Reiling, N., Lee, M. A., Ratner, L., Lane, C. M., Moore, M. S., Blobel, G., and Bukrinsky, M. (1998). Viral protein R regulates nuclear import of the HIV-1 pre-integration complex. EMBO J. 17(4), 909-917.
66. Prochiantz, A. (2000). Messenger proteins: Homeoproteins, Tat and others. Curr. Opin. Cell Biol. 12(4), 400-406.
67. Re, F., Braaten, D., Franke, E. K., and Luban, J. (1995). Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B. J. Virol. 69(11), 6859-6864.
68. Schubert, U., Bour, S., Willey, R. L., and Strebel, K. (1999). Regulation of virus release by the macrophage-tropic human immunodeficiency virus type 1 AD8 isolate is redundant and can be controlled by either Vpu or Env. J. Virol. 73(2), 887-896.
69. Schubert, U., Clouse, K. A., and Strebel, K. (1995). Augmentation of virus secretion by the human immunodeficiency virus type 1 Vpu protein is cell type independent and occurs in cultured human primary macrophages and lymphocytes. J. Virol. 69(12), 7699-7711.
70. Schuler, W., Wecker, K., de Rocquigny, H., Baudat, Y., Sire, J., and Roques, B. P. (1999). NMR structure of the (52-96) C-terminal domain of the HIV-1 regulatory protein Vpr. Molecular insights into its biological functions. J. Mol. Biol. 285(5), 2105-2117.
71. Schwarze, S. R., and Dowdy, S. F. (2000). In vivo protein transduction: Intracellular delivery of biologically active proteins, compounds and DNA. Trends Pharmacol. Sci. 21(2), 45-48.
72. Schwarze, S. R., Ho, A., Vocero-Akbani, A., and Dowdy, S. F. (1999). In vivo protein transduction: Delivery of a biologically active potein into the mouse [see comments]. Science 285(5433), 1569-1572.
73. Schwarze, S. R., Hruska, K. A., and Dowdy, S. F. (2000). Protein transduction: Unrestricted delivery into all cells? Trends Cell. Biol. 10(7), 290-295.
74. Sherman, M. P., de Noronha, C. M., Heusch, M. I., Greene, S., and Greene, W. C. (2001). Nucleocytoplasmic shuttling by human immunodeficiency virus type 1 Vpr. J. Virol. 75(3), 1522-1532.
75. Sherman, M. P., de Noronha, C. M., Pearce, D., and Greene, W. C. (2000) Human immunodeficiency virus type 1 Vpr contains two leucine-rich helices that mediate glucocorticoid receptor coactivation independently of its effects on G(2) cell cycle arrest. J. Virol. 74 (17), 8159-8165.
76. Sherman, M. P., and Greene, W. C. (2002). Slipping through the door: HIV entry into the nucleus. Microbes Infect. 4(1), 67-73.
77. Stewart, S. A., Poon, B., Jowett, J. B., and Chen, I. S. (1997). Human immunodeficiency virus type 1 Vpr induces apoptosis following cell cycle arrest. J. Virol. 71(7), 5579-5592.
78. Stewart, S. A., Poon, B., Jowett, J. B., Xie, Y., and Chen, I. S. (1999). Lentiviral delivery of HIV-1 Vpr protein induces apoptosis in transformed cells. Proc. Natl. Acad. Sci. USA 96(21), 12039-12043.
79. Stewart, S. A., Poon, B., Song, J. Y., and Chen, I. S. (2000). Human immunodeficiency virus type 1 Vpr induces apoptosis through caspase activation. J. Virol. 74(7), 3105-3111.
80. Subbramanian, R. A., Kessous-Elbaz, A., Lodge, R., Forget, J., Yao, X. J., Bergeron, D., and Cohen, E. A. (1998). Human immunodeficiency virus type 1 Vpr is a positive regulator of viral transcription and infectivity in primary human macrophages. J. Exp. Med. 187(7), 1103-1111.
81. Theodore, T. S., Englund, G., Buckler-White, A., Buckler, C. E., Martin, M. A., and Peden, K. W. (1996). Construction and characterization of a stable full-length macrophage-tropic HIV type 1 molecular clone that directs the production of high titers of progeny virions. AIDS Res. Hum. Retroviruses 12(3), 191-194.
82. Vives, E., Brodin, P., and Lebleu, B. (1997). A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272(25), 16010-16017.
83. von Schwedler, U., Kornbluth, R. S., and Trono, D. (1994). The nuclear localization signal of the matrix protein of human immunodeficiency virus type 1 allows the establishment of infection in macrophages and quiescent T lymphocytes. Proc. Natl. Acad. Sci. USA 91(15), 6992-6996.
84. Wecker, K., and Roques, B. P. (1999). NMR structure of the (1-51) N-terminal domain of the HIV-1 regulatory protein Vpr. Eur. J. Biochem. 266(2), 359-369.
85. Willey, R. L., Smith, D. H., Lasky, L. A., Theodore, T. S., Earl, P. L., Moss, B., Capon, D. J., and Martin, M. A. (1988). In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity. J. Virol. 62(1), 139-147.
86. Xu, X. N., Screaton, G. R., Gotch, F. M., Dong, T., Tan, R., Almond, N., Walker, B., Stebbings, R., Kent, K., Nagata, S., Stott, J. E., and Mc-Michael, A. J. (1997). Evasion of cytotoxic T lymphocyte (CTL) responses by Nef-dependent induction of Fas ligand (CD95L) expression on simian immunodeficiency virus-infected cells. J. Exp. Med. 186(1), 7-16.
87. Yao, X. J., Mouland, A. J., Subbramanian, R. A., Forget, J., Rougeau, N., Bergeron, D., and Cohen, E. A. (1998). Vpr stimulates viral expression and induces cell killing in human immunodeficiency virus type 1-infected dividing Jurkat T cells. J. Virol. 72(6), 4686-4693.
88. Yao, X. J., Subbramanian, R. A., Rougeau, N., Boisvert, F., Bergeron, D., and Cohen, E. A. (1995). Mutagenic analysis of human immunodeficiency virus type 1 Vpr: Role of a predicted N-terminal alpha-helical structure in Vpr nuclear localization and virion incorporation. J. Virol. 69 (11), 7032-7044.
89. Yedavalli, V. R., Chappey, C., and Ahmad, N. (1998). Maintenance of an intact human immunodeficiency virus type 1 Vpr gene following mother-to-infant transmission. J. Virol. 72(8), 6937-6943.
90. Yuan, X., Matsuda, Z., Matsuda, M., Essex, M., and Lee, T. H. (1990). Human immunodeficiency virus Vpr gene encodes a virion-associated protein. Aids Res. Hum. Retroviruses 6(11), 1265-1271.
91. Zennou, V., Petit, C., Guetard, D., Nerhbass, U., Montagnier, L., and Charneau, P. (2000). HIV-1 genome nuclear import is mediated by a central DNA flap. Cell 101(2), 173-185.
92. Zhao, L. J., Mukherjee, S., and Narayan, O. (1994a). Biochemical mechanism of HIV-1 Vpr function. Specific interaction with a cellular protein. J. Biol. Chem. 269(22), 15577-15582.
93. Zhao, L. J., Wang, L., Mukherjee, S., and Narayan, O. (1994b). Biochemical mechanism of HIV-1 Vpr function. Oligomerization mediated by the N-terminal domain. J. Biol. Chem. 269(51), 32131-32137.